These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27031984)

  • 1. Immune response to hepatitis B vaccination in a group of medical students in Sri Lanka.
    Noordeen F; Madushanka DG; Pitchai FN
    Ceylon Med J; 2016 Mar; 61(1):46. PubMed ID: 27031984
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka.
    Chathuranga LS; Noordeen F; Abeykoon AM
    Int J Infect Dis; 2013 Nov; 17(11):e1078-9. PubMed ID: 23810225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
    Marinho RT; Ramalho F; Velosa J
    Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B vaccine immunogenicity among nurses of a hospital.
    Piratheepkumar V; Kulendran S; Nadarajah S; Murugananthan K
    Ceylon Med J; 2014 Jun; 59(2):59-60. PubMed ID: 24977424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
    Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
    Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological response to hepatitis B vaccine in polytransfused thalassemic patients.
    Alavian SM; Tabatabaei SV
    Pediatr Hematol Oncol; 2010 May; 27(4):324-5; author reply 326-7. PubMed ID: 20426525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of markers for hepatitis B virus and vaccination compliance among medical school students in Italy.
    Trevisan A; Bruno A; Mongillo M; Morandin M; Pantaleoni A; Borella-Venturini M; Giraldo M
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1189-91. PubMed ID: 18973454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hepatitis B surface antigen in blood following vaccination.
    Bredberg A; Bøe OW; Bredberg J; Whist JE
    Vaccine; 2018 Aug; 36(33):4963-4965. PubMed ID: 29735322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies against hepatitis B after vaccination in health workers].
    Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
    Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 12. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 13. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.
    Romanò L; Zanetti AR
    J Prev Med Hyg; 2011 Jun; 52(2):45-6. PubMed ID: 21842704
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the DiaSorin LIAISON(®) anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott Architect anti-HBs assay.
    Kinn S; Akhavan S; Agut H; Thibault V
    J Clin Virol; 2011 Apr; 50(4):297-302. PubMed ID: 21330194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.